[ASCO-update 2015 - highlights of the 51. meeting of the american society of clinical oncology/ASCO 2015].

The field of gastrointestinal oncology is rapidly developing, on the one hand through the identification of novel molecular targets and therapeutic principles, on the other hand through the establishment and improvement of multidisciplinary treatment strategies. The following manuscript summarizes the most important trial results of the ASCO Meeting 2015 for gastrointestinal cancers. Besides trials on perioperative treatment of esophageal-, pancreatic- and colon cancer, we will present impressive data on new therapeutic strategies such as immunotherapy in gastric-, liver and microsatellite instable colorectal cancer. The trials will be put into context by the authors.

Lorenzen S ，Arnold D ，Fottner C ，Leichsenring J ，Moehler M ，Seufferlein T ，Vogel A ，Weber MM ，Reinacher-Schick A ... -  《-》

[ASCO-Update 2005--Highlights of the 41st Meeting of the American Society of Clinical Oncology/ASCO 2005].

Höhler T ，Heike M ，Lutz MP ，Graeven U ，Seufferlein T ，American Society of Clinical Oncology ... -  《ZEITSCHRIFT FUR GASTROENTEROLOGIE》

[ASCO update 2006--highlights of the 42. meeting of the American Society of Clinical Oncology/ASCO 2006].

Reinacher-Schick A ，Arnold D ，Lordick F ，Möhler M ，Lutz MP ，Seufferlein T ，American Society of Clinical Oncology/ASCO 2006 ... -  《ZEITSCHRIFT FUR GASTROENTEROLOGIE》

[ASCO update -- highlights of the 40th Meeting of the American Society of Clinical Oncology/ASCO 2004].

Graeven U ，Heike M ，Höhler T ，Lutz MP ，Messmann H ，Seufferlein T ，Eberl T ... -  《ZEITSCHRIFT FUR GASTROENTEROLOGIE》

Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Meeting.

To provide an overview of the key findings from studies in upper gastrointestinal, hepatobiliary, pancreas, and colorectal malignancies presented at ASCO GI 2022. We reviewed the abstracts presented at ASCO GI 2022. The studies highlighted were selected by the authors based on their significant discoveries and potential impact on clinical practice. This year's hybrid ASCO-GI symposium (2022) introduced many promising new treatment strategies in GI oncology, with several changes in clinical practice for patients with advanced hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic colorectal cancer (CRC).

Gholami S ，Abidalhassan M ，Cho M ，Saeed A ，Rocha FG ... -  《-》